Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ · Healthcare
Vertex Pharmaceuticals Incorporated EBITDA 2008–2025
Vertex Pharmaceuticals Incorporated annual/quarterly ebitda history and growth rate from 2008 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Vertex Pharmaceuticals Incorporated ebitda for the quarter ending March 31, 2026 was 1.2 B, a 75.98% increase year-over-year.
- Vertex Pharmaceuticals Incorporated ebitda for the twelve months ending March 31, 2026 was 4.3 B, a 1639.05% decrease year-over-year.
- Vertex Pharmaceuticals Incorporated annual ebitda for 2025 was 4.4 B, a 17154.86% decrease from 2024.
- Vertex Pharmaceuticals Incorporated annual ebitda for 2024 was -25.7 M, a 100.64% decrease from 2023.
- Vertex Pharmaceuticals Incorporated annual ebitda for 2023 was 4.0 B, a 9.93% decrease from 2022.
- Vertex Pharmaceuticals Incorporated annual ebitda for 2022 was 4.5 B.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Vertex Pharmaceuticals Inc. EBITDA — FAQ
Vertex Pharmaceuticals Inc. (VRTX) ebitda over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRTX's ebitda history?
The chart and table above show Vertex Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.